De Zhou

Agricultural and Biological SciencesEnvironmental ScienceEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial”.

Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial

Blood Cancer Journal(2025)10.1038/s41408-025-01404-8

N/A

0.165DataRank · unranked

2 citations

Wenjuan Yu, Mixue Xie, Ehsan Ghoushi, Xuelian Hu, Xin Huang +7 more

Dietary diversity indices v. dietary guideline-based indices and their associations with non-communicable diseases, overweight and energy intake: evidence from China

Public Health Nutrition(2022)10.1017/s1368980022000556

N/A

0DataRank · unranked

12 citations

Sirimaporn Leepromrath, De Zhou, Jiajun Zhou